SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : The Financial Collapse of 2001 Unwinding

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Cogito Ergo Sum who wrote (4962)3/25/2020 9:54:59 PM
From: Elroy Jetson  Read Replies (1) of 13795
 
Doctors are looking for a Covid treatment which provides a significant benefit beyond ventilators and a simple pneumonia antibiotic like zithromax to prevent the viral infection from proceeding to bacterial pneumonia.

If there's a benefit from taking hydroxychloroquine it's too small to be discerned by the 30 patient Chinese study. I've leaned to believe in the power of "statistically significant"
.

The likelihood of hydroxychloroquine providing a significant benefit to many patients in a much larger 3,000 person trial is essentially zero. That's how statistics work. A much larger trial of 3,000 patients might find a benefits to a small percentage of patients or a tiny benefit to perhaps 20% of patients.
.

The 40 patient French study showed a much slower clearance of virus than in China, both and without hydroxychloroquine. We no know the reported results are essentially meaningless.
Hydroxychloroquine, a medicine for malaria that President Donald Trump has touted as a treatment for coronavirus, was no more effective than conventional care, a small study found.
The report published by the Journal of Zhejiang University in China showed that patients who got the medicine didn’t fight off the new coronavirus more often than those who did not get the medicine.

The study involved just 30 patients. Of the 15 patients given the malaria drug, 13 tested negative for the coronavirus after a week of treatment. Of the 15 patients who didn’t get hydroxychloroquine, 14 tested negative for the virus.

The results of the study weren’t statistically significant. - bloomberg.com

Hydroxychloroquine, particularly when given with the antibiotic azithromycin, has received widespread attention following a controversial, small study of about 40 patients hospitalized with Covid-19 in France. In that study, the drug appeared to help clear the virus from the bodies of 26 patients who were given the medication, based on samples taken from nasal swabs. Experts have criticized the design of the study, calling it interesting but far from definitive.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext